State UT
Clinical Trials in Utah
Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 178 actively recruiting studies with Utah sites out of 178 registered in total. The busiest research areas in Utah are Malignant Neoplasm, Advanced Solid Tumor, Heart Failure. Leading sponsors running trials in the state include University of Utah, Eli Lilly and Company, National Cancer Institute (NCI). By stage, Utah trials break down as Phase 1 (30), Phase 2 (47), Phase 3 (49), Phase 4 (6).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Utah
Malignant Neoplasm (3)Advanced Solid Tumor (3)Heart Failure (3)Heart Diseases (3)Cardiovascular Diseases (3)Pulmonary Hypertension (3)Non-Small Cell Lung Cancer (3)Alopecia Areata (2)B Acute Lymphoblastic Leukemia (2)Treatment Resistant Depression (2)Pancreatic Ductal Adenocarcinoma (2)Ischemic Stroke (2)
Frequently Asked Questions — Clinical Trials in Utah
How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 178 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 178. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Malignant Neoplasm, Advanced Solid Tumor, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Utah
NCT06112418 N/A
Recruiting
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Pr...
Condition
Diabetes Mellitus, Type 2
Enrollment
7,500 pts
Location
United States
Sponsor
Cleerly, Inc.
NCT06478017 Phase 2
Recruiting
Belatacept in Heart Transplantation
Condition
Heart Transplant
Enrollment
66 pts
Location
United States
Sponsor
National Institute of Allergy
NCT07140783 Phase 3
Recruiting
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Kerato...
Condition
Vision Loss Night
Enrollment
580 pts
Location
United States
Sponsor
Ocuphire Pharma, Inc.
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
LEO Pharma
NCT03683251 Phase 3
Recruiting
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Condition
Neovascular Age-Related Macular Degeneration
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT06357754 N/A
Recruiting
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Br...
Condition
Non-Hodgkin Lymphoma
Enrollment
50 pts
Location
United States, Germany, Japan
Sponsor
Bristol-Myers Squibb
NCT07061977 Phase 3
Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemor...
Condition
Locally Advanced Cervical Adenocarcinoma
Enrollment
336 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07614776 Phase 3
Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versu...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
304 pts
Location
United States, Latvia, Poland
Sponsor
Amgen
NCT07052903 Phase 3
Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloid...
Condition
Transthyretin Amyloidosis With Cardiomyopathy
Enrollment
1,750 pts
Location
United States, Argentina, Australia
Sponsor
Alnylam Pharmaceuticals
NCT06568939 Phase 2
Recruiting
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzuma...
Condition
Non-Small Cell Lung Cancer
Enrollment
150 pts
Location
United States, Brazil, China
Sponsor
AbbVie
NCT04973605 Phase 1, Phase 2
Recruiting
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Comb...
Condition
Relapsed/Refractory Multiple Myeloma
Enrollment
246 pts
Location
United States, Australia, Brazil
Sponsor
BeOne Medicines
NCT04726241 Phase 1, Phase 2
Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marr...
Condition
Acute Lymphoblastic Leukemia
Enrollment
960 pts
Location
United States, Australia, Canada
Sponsor
PedAL BCU, LLC
NCT05732831 Phase 1, Phase 2
Recruiting
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Condition
Locally Advanced Solid Tumor
Enrollment
225 pts
Location
United States, France, Spain
Sponsor
Tango Therapeutics, Inc.
NCT06150716 Phase 1
Recruiting
Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynam...
Condition
Pelizaeus-Merzbacher Disease
Enrollment
24 pts
Location
United States, France, Germany
Sponsor
Ionis Pharmaceuticals, Inc.
NCT06598943 Phase 2
Recruiting
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Seve...
Condition
Ulcerative Colitis
Enrollment
143 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
NCT04071847 N/A
Recruiting
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Condition
Movement Disorders
Enrollment
1,000 pts
Location
United States, Australia, Finland
Sponsor
Abbott Medical Devices
NCT06980948 Phase 1, Phase 2
Recruiting
Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Ne...
Condition
Chronic Neuropathic Pain
Enrollment
27 pts
Location
United States
Sponsor
Sangamo Therapeutics
NCT07205887 Phase 2
Recruiting
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular...
Condition
Neovascular Age-Related Macular Degeneration (NVAMD)
Enrollment
160 pts
Location
United States
Sponsor
EyeBiotech Ltd.
NCT06932887 Phase 3
Recruiting
The Beat Pain Better Trial
Condition
Osteoarthritis
Enrollment
346 pts
Location
United States
Sponsor
University of Utah
NCT05765812 Phase 1, Phase 2
Recruiting
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants Wit...
Condition
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Enrollment
116 pts
Location
United States, Spain, Switzerland
Sponsor
Debiopharm International SA
NCT07486934 Phase 3
Recruiting
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Partic...
Condition
Myotonic Dystrophy Type 1 (DM1)
Enrollment
150 pts
Location
United States, Australia, Belgium
Sponsor
Dyne Therapeutics
NCT07136012 Phase 3
Recruiting
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a)...
Condition
Cardiovascular Disease
Enrollment
11,000 pts
Location
United States, Australia, Canada
Sponsor
Amgen
NCT05812807 Phase 3
Recruiting
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who H...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
1,295 pts
Location
United States, Canada, Puerto Rico
Sponsor
Alliance for Clinical Trials i
NCT04176198 Phase 1, Phase 2
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Condition
Myelofibrosis
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
Sumitomo Pharma America, Inc.
NCT04511806 N/A
Recruiting
Childhood Cancer Predisposition Study (CCPS)
Condition
Pediatric Cancer
Enrollment
1,050 pts
Location
United States, Canada
Sponsor
Emory University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology